Pennington, NJ, United States of America

Praveen Kumar Mididoddi

USPTO Granted Patents = 5 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Praveen Kumar Mididoddi: Innovator in Pharmaceutical Formulations

Introduction

Praveen Kumar Mididoddi is a notable inventor based in Pennington, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative formulations. With a total of 5 patents to his name, Mididoddi continues to push the boundaries of pharmaceutical science.

Latest Patents

Among his latest patents is the invention titled "Centanafadine pharmaceutical formulations, and methods of making and using same." This patent discloses a pharmaceutical formulation comprising centanafadine or a pharmaceutically acceptable salt thereof, along with an excipient. The related methods of manufacture and use are also detailed in this patent, showcasing Mididoddi's expertise in creating effective pharmaceutical solutions.

Career Highlights

Praveen Kumar Mididoddi is currently associated with Otsuka Pharmaceutical Company, Limited, where he applies his knowledge and skills to advance pharmaceutical research and development. His work has been instrumental in creating formulations that can potentially improve patient outcomes.

Collaborations

Mididoddi collaborates with talented professionals in his field, including Syed Asfar Mateen and Shailly Mehrotra. These collaborations enhance the innovative capacity of his projects and contribute to the success of their collective efforts.

Conclusion

Praveen Kumar Mididoddi is a distinguished inventor whose work in pharmaceutical formulations is paving the way for advancements in medicine. His contributions are vital to the ongoing evolution of pharmaceutical science, and his patents reflect a commitment to improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…